Author:
Pipatpajong Somchanin,Tangkulboriboon Rachata
Abstract
Objective: To determine preoperative factors associated with underestimation of invasive breast cancer, where stereotactic vacuum-assisted biopsy (VAB) diagnosed as ductal carcinoma in situ (DCIS).
Materials and Methods: Data from 95 patients diagnosed with DCIS by stereotactic VAB, including their clinical, radiological, and pathological findings between November 2010 and May 2021, were analyzed retrospectively. The clinical, radiological, and pathological features were analyzed.
Results: The underestimation rate was 30.5 %. Three preoperative features were significantly associated with the underestimation of invasive breast cancer in multivariable analysis, including palpability (OR, 11.51; 95% CI: 1.817-72.897; P = 0.009), BI-RADS category (OR, 3.705; 95% CI: 1.214-11.303; P = 0.021), and visibility of a mammographically detected lesion at ultrasonography (OR, 7.115; 95% CI: 1.977-25.611; P = 0.003). The calcification morphology was statistically significant in an univariable analysis but not in a multivariable analysis.
Conclusion: Preoperative variables significantly associated with underdiagnosis of invasive breast cancer, including palpability, BI-RADS category, and visibility of mammographically detected lesions at ultrasonography, could aid in assessing the risk of developing invasive breast cancer and conducting treatment selection.
Publisher
Foundation for Orphan and Rare Lung Disease (FORLD)
Reference17 articles.
1. Parikh U, Chhor CM, Mercado CL. Ductal carcinoma in situ: the whole truth. AJR Am J Roentgenol 2018;210:246-55. doi: 10.2214/AJR.17.18778.
2. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 3.2019) [Internet].NCCN;2019 Sept 6 [cited 2023 Jul 2]. Available from: https://www2.tri-kobe.org/nccn/guideline/archive/breast2019/english/breast_v3.pdf
3. Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, et al. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation andpredictors of invasive breast cancer. Radiology 2011;260:119-28. doi: 10.1148/radiol.11102368.
4. Kim J, Han W, Lee JW, You JM, Shin HC, Ahn SK, et al. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast 2012 ;21:641-5 . doi: 10.1016/j.breast.2012.06.012.
5. Meurs CJC, van Rosmalen J, Menke-Pluijmers MBE, Ter Braak BPM, de Munck L, et al. A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers. Br J Cancer 2018;119:1155-62. doi: 10.1038/s41416-018-0276-6.